Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants.

BACKGROUND the apolipoprotein (APOE) e4 locus is a genetic risk factor for dementia. Carriers of the e4 allele may be more vulnerable to conditions that are independent risk factors for cognitive decline, such as cardiometabolic diseases. OBJECTIVE we tested whether any association with APOE e4 status on cognitive ability was larger in older ages or in those with cardiometabolic diseases. SUBJECTS UK Biobank includes over 500,000 middle- and older aged adults who have undergone detailed medical and cognitive phenotypic assessment. Around 150,000 currently have genetic data. We examined 111,739 participants with complete genetic and cognitive data. METHODS baseline cognitive data relating to information processing speed, memory and reasoning were used. We tested for interactions with age and with the presence versus absence of type 2 diabetes (T2D), coronary artery disease (CAD) and hypertension. RESULTS in several instances, APOE e4 dosage interacted with older age and disease presence to affect cognitive scores. When adjusted for potentially confounding variables, there was no APOE e4 effect on the outcome variables. CONCLUSIONS future research in large independent cohorts should continue to investigate this important question, which has potential implications for aetiology related to dementia and cognitive impairment.

[1]  A Hofman,et al.  Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949) , 2015, Molecular Psychiatry.

[2]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[3]  K. Hawkins,et al.  The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis , 2011, Neurobiology of Aging.

[4]  J M Starr,et al.  APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921 , 2012, Molecular Psychiatry.

[5]  M. Alberts,et al.  APOE genotype as a risk factor for ischemic cerebrovascular disease , 1999, Neurology.

[6]  Lorna M. Lopez,et al.  A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing , 2014, Molecular Psychiatry.

[7]  I. Deary,et al.  Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity? , 2014, Translational Psychiatry.

[8]  Jonathan D. Smith,et al.  Apolipoproteins and aging: emerging mechanisms , 2002, Ageing Research Reviews.

[9]  P. Wolf,et al.  APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[10]  Ulman Lindenberger,et al.  Aging-related magnification of genetic effects on cognitive and brain integrity , 2015, Trends in Cognitive Sciences.

[11]  J. Slaets,et al.  The Association of APOE Genotype with Cognitive Function in Persons Aged 35 Years or Older , 2011, PloS one.

[12]  I. Deary,et al.  ADRB2, brain white matter integrity and cognitive ageing in the Lothian Birth Cohort 1936 , 2012, Behavior Genetics.

[13]  C. Sudlow,et al.  Accuracy of Electronic Health Record Data for Identifying Stroke Cases in Large-Scale Epidemiological Studies: A Systematic Review from the UK Biobank Stroke Outcomes Group , 2015, PloS one.

[14]  S. Rapcsak,et al.  Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers , 2011, Neurology.

[15]  J. Jia,et al.  Meta-analysis of APOE4 allele and outcome after traumatic brain injury. , 2008, Journal of neurotrauma.

[16]  P. Visscher,et al.  Apolipoprotein e gene variability and cognitive functions at age 79: a follow-up of the Scottish mental survey of 1932. , 2004, Psychology and aging.

[17]  J. Gallacher,et al.  Cognitive function and lifetime features of depression and bipolar disorder in a large population sample: Cross-sectional study of 143,828 UK Biobank participants , 2015, European Psychiatry.

[18]  B. Penninx,et al.  Salivary cortisol, APOE-ε4 allele and cognitive decline in a prospective study of older persons , 2011, Neurobiology of Aging.

[19]  D. Rujescu,et al.  Apolipoprotein E e4 and Cognitive Function: A Modifiable Association? Results from Two Independent Cohort Studies , 2015, Dementia and Geriatric Cognitive Disorders.

[20]  R. Marioni,et al.  Differential effects of the APOE e4 allele on different domains of cognitive ability across the life-course , 2015, European Journal of Human Genetics.

[21]  Jonathan Flint,et al.  Confidence and precision increase with high statistical power , 2013, Nature Reviews Neuroscience.

[22]  Martin Lövdén,et al.  Genetic effects on old-age cognitive functioning: a population-based study. , 2013, Psychology and aging.

[23]  Jonathan J. Evans,et al.  Prevalence and Characteristics of Probable Major Depression and Bipolar Disorder within UK Biobank: Cross-Sectional Study of 172,751 Participants , 2013, PloS one.